BSE filing, NSE: SESHAPAPER. Summary written from the filing by ALFA Finder's alert engine.
Seshasayee Paper & Boards Ltd: key numbers
- Share price
- ₹202.00
- Market cap
- ₹1,274 Cr
- Revenue (annual)
- ₹1,710 Cr
- Net profit (annual)
- ₹82.53 Cr
- P/E (TTM)
- 10.7×Sector 36.4×
- Promoter holding
- 43.30%+0.03% QoQ
- FII holding
- 12.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Seshasayee Paper & Boards Ltd
All →Seshasayee Paper & Boards Promoter Buying: ₹12.25 Cr
Time Square Investments, a promoter group entity, bought 570,000 Seshasayee Paper shares via market purchase for Rs.12.25 Crore. Promoter stake rises from 10.22% to 11.12%.
- Value
- ₹12.25 Cr
- Promoter stake change
- +0.90%
Seshasayee Paper & Boards Promoter Buying: ₹122.5 Cr
Promoter group entity Time Square Investments bought 5,70,000 Seshasayee Paper shares on NSE, lifting its stake to 11.125%. The open-market purchase is worth about Rs 122.55 Crore.
- Value
- ₹122.5 Cr
- Promoter stake change
- +0.90%
Seshasayee Paper & Boards Promoter Buying: ₹3.01 Cr
Promoter-group entity High Energy Batteries bought 1,40,000 Seshasayee Paper shares on NSE at ₹214.90 each, worth ₹3.01 Crore. Its stake rose to 0.391%.
- Value
- ₹3.01 Cr
- Promoter stake change
- +0.22%
Seshasayee Paper & Boards Q2 FY27 Results: Net Profit ₹42.3 Cr, Up 88.8% YoY
Seshasayee Paper & Boards Ltd reported revenue from operations of ₹503.1 Cr (+45.3% YoY) and net profit of ₹42.3 Cr (+88.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹42.3 Cr · +88.8% YoY
Seshasayee Paper & Boards Capital Structure Change
Atyant Capital India Fund 1 sold 13.03 lakh shares of Seshasayee Paper and Boards Limited via open market transactions.
Seshasayee Paper & Boards Board Meeting Date
Seshasayee Paper and Boards Limited has scheduled a board meeting for October 24, 2026. The board will consider unaudited financial results for the quarter and half-year ended September 30, 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.